ArticleJournal of gastrointestinal oncology2025
The clinical efficacy and pathological assessment of neoadjuvant imatinib treatment in patients with primary gastrointestinal stromal tumors.
Chunhui Shou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.